Cargando…
Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens
While regulatory requirements for carcinogenicity testing of chemicals vary according to product sector and regulatory jurisdiction, the standard approach starts with a battery of genotoxicity tests (which include mutagenicity assays). If any of the in vivo genotoxicity tests are positive, a lifetim...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395040/ https://www.ncbi.nlm.nih.gov/pubmed/32594184 http://dx.doi.org/10.1007/s00204-020-02784-5 |
_version_ | 1783565323184635904 |
---|---|
author | Jacobs, Miriam N. Colacci, Annamaria Corvi, Raffaella Vaccari, Monica Aguila, M. Cecilia Corvaro, Marco Delrue, Nathalie Desaulniers, Daniel Ertych, Norman Jacobs, Abigail Luijten, Mirjam Madia, Federica Nishikawa, Akiyoshi Ogawa, Kumiko Ohmori, Kiyomi Paparella, Martin Sharma, Anoop Kumar Vasseur, Paule |
author_facet | Jacobs, Miriam N. Colacci, Annamaria Corvi, Raffaella Vaccari, Monica Aguila, M. Cecilia Corvaro, Marco Delrue, Nathalie Desaulniers, Daniel Ertych, Norman Jacobs, Abigail Luijten, Mirjam Madia, Federica Nishikawa, Akiyoshi Ogawa, Kumiko Ohmori, Kiyomi Paparella, Martin Sharma, Anoop Kumar Vasseur, Paule |
author_sort | Jacobs, Miriam N. |
collection | PubMed |
description | While regulatory requirements for carcinogenicity testing of chemicals vary according to product sector and regulatory jurisdiction, the standard approach starts with a battery of genotoxicity tests (which include mutagenicity assays). If any of the in vivo genotoxicity tests are positive, a lifetime rodent cancer bioassay may be requested, but under most chemical regulations (except plant protection, biocides, pharmaceuticals), this is rare. The decision to conduct further testing based on genotoxicity test outcomes creates a regulatory gap for the identification of non-genotoxic carcinogens (NGTxC). With the objective of addressing this gap, in 2016, the Organization of Economic Cooperation and Development (OECD) established an expert group to develop an integrated approach to the testing and assessment (IATA) of NGTxC. Through that work, a definition of NGTxC in a regulatory context was agreed. Using the adverse outcome pathway (AOP) concept, various cancer models were developed, and overarching mechanisms and modes of action were identified. After further refining and structuring with respect to the common hallmarks of cancer and knowing that NGTxC act through a large variety of specific mechanisms, with cell proliferation commonly being a unifying element, it became evident that a panel of tests covering multiple biological traits will be needed to populate the IATA. Consequently, in addition to literature and database investigation, the OECD opened a call for relevant assays in 2018 to receive suggestions. Here, we report on the definition of NGTxC, on the development of the overarching NGTxC IATA, and on the development of ranking parameters to evaluate the assays. Ultimately the intent is to select the best scoring assays for integration in an NGTxC IATA to better identify carcinogens and reduce public health hazards. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-020-02784-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7395040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-73950402020-08-18 Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens Jacobs, Miriam N. Colacci, Annamaria Corvi, Raffaella Vaccari, Monica Aguila, M. Cecilia Corvaro, Marco Delrue, Nathalie Desaulniers, Daniel Ertych, Norman Jacobs, Abigail Luijten, Mirjam Madia, Federica Nishikawa, Akiyoshi Ogawa, Kumiko Ohmori, Kiyomi Paparella, Martin Sharma, Anoop Kumar Vasseur, Paule Arch Toxicol Meeting Reports While regulatory requirements for carcinogenicity testing of chemicals vary according to product sector and regulatory jurisdiction, the standard approach starts with a battery of genotoxicity tests (which include mutagenicity assays). If any of the in vivo genotoxicity tests are positive, a lifetime rodent cancer bioassay may be requested, but under most chemical regulations (except plant protection, biocides, pharmaceuticals), this is rare. The decision to conduct further testing based on genotoxicity test outcomes creates a regulatory gap for the identification of non-genotoxic carcinogens (NGTxC). With the objective of addressing this gap, in 2016, the Organization of Economic Cooperation and Development (OECD) established an expert group to develop an integrated approach to the testing and assessment (IATA) of NGTxC. Through that work, a definition of NGTxC in a regulatory context was agreed. Using the adverse outcome pathway (AOP) concept, various cancer models were developed, and overarching mechanisms and modes of action were identified. After further refining and structuring with respect to the common hallmarks of cancer and knowing that NGTxC act through a large variety of specific mechanisms, with cell proliferation commonly being a unifying element, it became evident that a panel of tests covering multiple biological traits will be needed to populate the IATA. Consequently, in addition to literature and database investigation, the OECD opened a call for relevant assays in 2018 to receive suggestions. Here, we report on the definition of NGTxC, on the development of the overarching NGTxC IATA, and on the development of ranking parameters to evaluate the assays. Ultimately the intent is to select the best scoring assays for integration in an NGTxC IATA to better identify carcinogens and reduce public health hazards. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00204-020-02784-5) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-06-27 2020 /pmc/articles/PMC7395040/ /pubmed/32594184 http://dx.doi.org/10.1007/s00204-020-02784-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Meeting Reports Jacobs, Miriam N. Colacci, Annamaria Corvi, Raffaella Vaccari, Monica Aguila, M. Cecilia Corvaro, Marco Delrue, Nathalie Desaulniers, Daniel Ertych, Norman Jacobs, Abigail Luijten, Mirjam Madia, Federica Nishikawa, Akiyoshi Ogawa, Kumiko Ohmori, Kiyomi Paparella, Martin Sharma, Anoop Kumar Vasseur, Paule Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens |
title | Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens |
title_full | Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens |
title_fullStr | Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens |
title_full_unstemmed | Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens |
title_short | Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens |
title_sort | chemical carcinogen safety testing: oecd expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens |
topic | Meeting Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395040/ https://www.ncbi.nlm.nih.gov/pubmed/32594184 http://dx.doi.org/10.1007/s00204-020-02784-5 |
work_keys_str_mv | AT jacobsmiriamn chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT colacciannamaria chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT corviraffaella chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT vaccarimonica chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT aguilamcecilia chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT corvaromarco chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT delruenathalie chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT desaulniersdaniel chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT ertychnorman chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT jacobsabigail chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT luijtenmirjam chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT madiafederica chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT nishikawaakiyoshi chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT ogawakumiko chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT ohmorikiyomi chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT paparellamartin chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT sharmaanoopkumar chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens AT vasseurpaule chemicalcarcinogensafetytestingoecdexpertgroupinternationalconsensusonthedevelopmentofanintegratedapproachforthetestingandassessmentofchemicalnongenotoxiccarcinogens |